Le Lézard
Classified in: Health, Science and technology, Business
Subjects: HSP, BLK, CXP

Microbiologics expands virology capabilities for SARS-CoV-2 with new BSL-3 laboratory at its San Diego facility

SAN DIEGO, Aug. 3, 2020 /PRNewswire/ -- Microbiologics announced today that it has recently completed renovations of the virology services laboratory in its San Diego location. With completion of the renovation, Microbiologics has expanded its custom virology solutions to include Biosafety Level 3 (BSL-3) antiviral services. With these new capabilities, Microbiologics has launched a menu of cell-based services for SARS-CoV-2 to assist assay developers, evaluate therapeutic solutions and vaccines, and provide inactivated intact virus to researchers and diagnostic companies.

Microbiologics has also expanded its viral capabilities to include reverse genetics systems to create recombinant viruses, increased in-vitro assay capabilities, including cytopathic effect screening, hemagglutination-inhibition testing (HAI), neutralization assays, and yield-reduction assays. The newly renovated space also allows for increased capacity for viral propagation of high-titer stock materials. Microbiologics has also recently completed its process for ISO 13485 accreditation at the San Diego Facility.

Additional information about the complete virology services offered at Microbiologics is available by email at VirologyServices@microbiologics.com.

Visit microbiologics.com/virology to learn more.

About Microbiologics

Microbiologics, the leading global provider of infectious disease biomaterials. Microbiologics has provided clinical, food, water, pharmaceutical and cosmetic laboratories with reliable, ready-to-use microbial reference materials for nearly 50 years. The company has a distribution network that reaches more than 140 countries worldwide.

Microbiologics acquired San Diego based Virapur in 2017 expanding its research and development support services to therapeutics, vaccines and gene therapy, as well as broaden its viral molecular controls portfolio.

Karin Pauly


SOURCE Microbiologics

These press releases may also interest you

at 21:10
PAR Technology Corporation , a leading global provider of point of sale (POS) software, hardware and integrated technical solutions to the restaurant and retail industries, today announced the pricing of an underwritten public offering of 3,350,000...

at 21:05
Tech Data today announced it has completed its acquisition of Innovix Distribution, a leading technology distributor in Asia. This acquisition expands Tech Data's presence across the Asia Pacific region and strengthens its end-to-end solutions...

at 21:00
IBEX Technologies Inc. ("IBEX" or the "Company") is pleased to announce that Belinda Franco, CPA, CA has joined IBEX and will become Director of Finance and Chief Financial Officer. "Belinda brings a wealth of experience to the role and will be a...

at 21:00
CYFIRMA K.K., a threat discovery and cyber intelligence platform company funded by Goldman Sachs, Zodius Capital and Z3Partners (Headquarter: Chiyoda-ku, Tokyo, Representative Director: Kumar Ritesh, CYFIRMA) and NTT DATA INTELLILINK Corporation...

at 21:00
Veravas, Inc. an early-stage biotechnology company, announced today that it has received Conformité Européene (CE) Mark approval for its suite of IVD interference detection and mitigation products. VeraTest Biotintm is a colloidal gold-based lateral...

at 20:41
On Sept. 30, NASA's Marshall Space Flight Center in Huntsville, Alabama, virtually presented its Industry & Advocate Awards for fiscal year 2020. The awards reflect leadership in the aerospace business community and sustained achievement in service...

News published on 3 august 2020 at 14:24 and distributed by: